Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Change in Account Payables: 2020-2024

Historic Change in Account Payables for Pyxis Oncology (PYXS) over the last 5 years, with Dec 2024 value amounting to $1.2 million.

  • Pyxis Oncology's Change in Account Payables rose 157.14% to $344,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is 134.22% up from last year.
  • Per Pyxis Oncology's latest filing, its Change in Account Payables stood at $1.2 million for FY2024, which was up 134.22% from -$3.5 million recorded in FY2023.
  • Pyxis Oncology's Change in Account Payables' 5-year high stood at $4.6 million during FY2021, with a 5-year trough of -$8.3 million in FY2022.
  • Moreover, its 3-year median value for Change in Account Payables was -$3.5 million (2023), whereas its average is -$3.5 million.
  • As far as peak fluctuations go, Pyxis Oncology's Change in Account Payables skyrocketed by 732.08% in 2021, and later plummeted by 279.37% in 2022.
  • Over the past 5 years, Pyxis Oncology's Change in Account Payables (Yearly) stood at $558,000 in 2020, then soared by 732.08% to $4.6 million in 2021, then slumped by 279.37% to -$8.3 million in 2022, then soared by 57.89% to -$3.5 million in 2023, then soared by 134.22% to $1.2 million in 2024.